化合物SD-208 T2109
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
2 mg | 627536-09-8 | ¥246.00 | 询底价 |
10 mg | 627536-09-8 | ¥633.00 | 询底价 |
100 mg | 627536-09-8 | ¥2,970.00 | 询底价 |
1 mg | 627536-09-8 | ¥177.00 | 询底价 |
50 mg | 627536-09-8 | ¥1,970.00 | 询底价 |
25 mg | 627536-09-8 | ¥1,280.00 | 询底价 |
1 mL | 627536-09-8 | ¥695.00 | 询底价 |
5 mg | 627536-09-8 | ¥392.00 | 询底价 |
Product Introduction
Bioactivity
英文名: SD-208
描述: SD-208 (ALK5 Inhibitor V) 是 TGF-βRI (ALK5) 的选择性抑制剂(IC50:48 nM),对其选择性是对 TGF-βRII 的 100 多倍。
细胞实验: Glioma cells are cultured in the absence or presence of SD-208 (1 μM) for 48 hours. The cells are pulsed for the last 24 hours with [methyl-3H]thymidine (0.5 μCi) and harvested, and incorporated radioactivity is determined in a liquid scintillation counter.(Only for Reference)
激酶实验: Kinase assay: Various kinase activities are assayed by measuring the incorporation of radiolabeled ATP into a peptide or protein substrate. The reactions are performed in 96-well plates and included the relevant kinase, substrate, ATP, and appropriate cofactors. The reactions are incubated and then stopped by the addition of phosphoric acid. Substrate is captured onto a phosphocellulose filter, which is washed free of unreacted ATP. The counts incorporated are determined by counting on a microplate scintillation counter. The ability of SD-208 to inhibit the respective kinase is determined by comparing counts incorporated in the presence of compound with those incorporated in the absence of compound.
体外活性: SD-208(1 mg/mL,p.o.)使负荷SMA-560胶质瘤小鼠的中值存活率显著延长.在同源129S1小鼠体内,SD-208(60 mg/kg,p.o.)抑制初级R3T肿瘤生长,并使肺转移的数量及大小减少.在小鼠大动脉同种移植模型中,SD-208可有效减少移植动脉硬化内膜增生的形成.
体内活性: 在体外,SD-208阻断TGF-β诱导的受体相关Smads,Smad/3磷酸化,且对上皮细胞到间叶细胞的分化转化、迁移及侵袭到基底膜具有刺激作用。在体外,SD-208还可阻断TGF-β对新生内膜平滑肌样细胞迁移与增殖的保护作用。在小鼠SMA-560和人SMA-560胶质瘤细胞中,SD-208抑制细胞生长、组成及转化生长因子-β诱发的迁移和浸润,并使免疫原性增强。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 7.1 mg/mL (20 mM)
关键字: inhibit | Transforming growth factor beta receptors | TGF-β Receptor | Inhibitor | SD 208 | SD-208
相关产品: SM1-71 | SRI-011381 | Chebulinic acid | Dalbergioidin | Ponsegromab | LDN-212854 | AXL-IN-13 | HALOFUGINONE LACTATE | LDN193189 | Disitertide acetate
相关库: Anti-Aging Compound Library | HIF-1 Signaling Pathway Compound Library | Inhibitor Library | Kinase Inhibitor Library | Anti-Obesity Compound Library | Anti-Cancer Active Compound Library | Highly Selective Inhibitor Library | Tyrosine Kinase Inhibitor Library | TGF-beta/Smad Compound Library | Preclinical Compound Library
化合物SD-208 T2109信息由TargetMol中国为您提供,如您想了解更多关于化合物SD-208 T2109报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途